Gufic Biosciences
Gufic Biosciences launches dual chamber bags for drug delivery; eyes dominant share in the segment
Kolkata: High-quality pharmaceutical and herbal products maker Gufic Biosciences Ltd Thursday launched affordably priced dual chamber bags for drug delivery.
The company has collaborated with its French counterpart to manufacture this new technology indigenously in India.
Until now the dual chamber bags were being imported, adding to patients' cost burden.
Gufic Biosciences said its high quality dual chamber bags have longer shelf -life.
Contributing immensely to the government’s ambitious Make in India drive Gufic Biosciences
Gufic Biosciences COO Dr. Debesh Das said, “Our indigenously produced Dual Chamber Bags are pocket-friendly and meet global standards. As we are experiencing rapidly growing demand for our product we look forward to grabbing major market share in this particular segment.”
These are 2-Chamber IV Bags made of polypropylene (DEHP free) with a peelable aluminium foil allowing the storage of unstable drugs which need a reconstitution just before the administration to the patient.
The peelable seal separates lyophilized (or powder) drug and its diluent.
The product complies with the US and EU pharmacopoeias and it is manufactured in ISO7 cleanroom under cGMP, the company said.
The bag's closed system ensures that the product is sterile and avoids risks of contamination during handling and
reduces risk of bloodstream infections and thereby ensures Patient's safety.
Stability of the drug is much more in DCB rather than vials as it provides complete protection from light & moisture
"These bags also offer ease of handling at the time of reconstitution and also help in avoiding the dilution errors since the drug is present with the exact required quantity of the diluent to be used. It can be reconstituted just before administration by simply peeling off the aluminium foil and folding & squeezing the bag, thus the diluent enters the drug chamber and mixes with the drug. It is then directly administered as IV infusion to the patient with the help of IV tubes," the company said in a statement at the launch of the product.
Gufic Biosciences is one of the largest manufacturers of Lyophilized injections in India and has a fully automated lyophilization plant.
The company’s lyophillized product portfolio includes antibiotic, antifungal, cardiac, infertility, antiviral and proton-pump inhibitor segments, among others.
Gufic Biosciences said it is targeting a major share of Rs 3000 crore lyophilized antibiotics antifungal market in India.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
